WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IONS

Based on 20 analysts offering 12 month price targets for Ionis Pharmaceuticals Inc

Min Forecast
$46.00-44.36%
Avg Forecast
$86.80+5%
Max Forecast
$110.00+33.06%

Should I buy or sell IONS stock?

Based on 20 analysts offering ratings for Ionis Pharmaceuticals Inc.

Strong Buy
Strong Buy
11 analysts 55%
Buy
6 analysts 30%
Hold
3 analysts 15%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IONS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IONS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their IONS stock forecasts and price targets.

IONS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-05Find Out Why
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-12-15
lockedlocked$00.00+00.00%2025-12-09Find Out Why
lockedlocked$00.00+00.00%2025-11-10
Piper Sandler
Top 8%
93
Strong BuyMaintains$77.00-6.86%2025-11-04Find out why
TD Cowen
Top 28%
73
Strong BuyMaintains$99.00+19.75%2025-10-30
Morgan Stanley
Top 10%
91
Strong BuyMaintains$94.00+13.71%2025-10-30Find out why
Barclays
Top 28%
73
Strong BuyMaintains$95.00+14.91%2025-10-30
Raymond James
Top 36%
65
Strong BuyReiterates$89.00+7.66%2025-10-30

1 of 2

Forecast return on equity

Is IONS forecast to generate an efficient return?

Company
98.39%
Industry
352.12%
Market
211.34%
IONS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IONS forecast to generate an efficient return on assets?

Company
20.05%
Industry
122.26%
IONS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IONS earnings per share forecast

What is IONS's earnings per share in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
-$3.18
Avg 2 year Forecast
-$1.58
Avg 3 year Forecast
$1.61

IONS revenue forecast

What is IONS's revenue in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
$918.7M-4.99%
Avg 2 year Forecast
$1.4B+41.79%
Avg 3 year Forecast
$1.8B+91.12%
IONS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IONS revenue growth forecast

How is IONS forecast to perform vs Biotechnology companies and vs the US market?

Company
23.98%
Industry
116.92%
Market
23.08%
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IONS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IONS$82.67$86.80+5.00%Strong Buy
ASND$226.10$278.36+23.12%Strong Buy
BBIO$77.27$85.93+11.21%Strong Buy
ROIV$21.62$24.31+12.46%Strong Buy
MDGL$489.31$666.82+36.28%Strong Buy
View Top Biotech Stocks

Ionis Pharmaceuticals Stock Forecast FAQ

Is Ionis Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 20 Wall Street analysts covering (NASDAQ: IONS) stock is to Strong Buy IONS stock.

Out of 20 analysts, 11 (55%) are recommending IONS as a Strong Buy, 6 (30%) are recommending IONS as a Buy, 3 (15%) are recommending IONS as a Hold, 0 (0%) are recommending IONS as a Sell, and 0 (0%) are recommending IONS as a Strong Sell.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

What is IONS's earnings growth forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Ionis Pharmaceuticals's earnings in 2026 is -$256,342,000.On average, 25 Wall Street analysts forecast IONS's earnings for 2026 to be -$514,333,488, with the lowest IONS earnings forecast at -$690,496,837, and the highest IONS earnings forecast at -$256,810,400. On average, 19 Wall Street analysts forecast IONS's earnings for 2027 to be -$256,470,254, with the lowest IONS earnings forecast at -$448,102,158, and the highest IONS earnings forecast at -$1,700,731.

In 2028, IONS is forecast to generate $260,811,168 in earnings, with the lowest earnings forecast at -$60,319,264 and the highest earnings forecast at $545,934,692.

What is IONS's revenue growth forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual revenue growth rate of 23.98% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Ionis Pharmaceuticals's revenue in 2026 is $966,956,000.On average, 25 Wall Street analysts forecast IONS's revenue for 2026 to be $148,804,255,105, with the lowest IONS revenue forecast at $109,023,344,184, and the highest IONS revenue forecast at $190,643,860,561. On average, 19 Wall Street analysts forecast IONS's revenue for 2027 to be $222,066,892,803, with the lowest IONS revenue forecast at $164,889,932,074, and the highest IONS revenue forecast at $336,906,737,440.

In 2028, IONS is forecast to generate $299,328,678,264 in revenue, with the lowest revenue forecast at $239,560,127,247 and the highest revenue forecast at $350,998,509,631.

What is IONS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IONS) forecast ROA is 20.05%, which is lower than the forecast US Biotechnology industry average of 122.26%.

What is IONS's Price Target?

According to 20 Wall Street analysts that have issued a 1 year IONS price target, the average IONS price target is $86.80, with the highest IONS stock price forecast at $110.00 and the lowest IONS stock price forecast at $46.00.

On average, Wall Street analysts predict that Ionis Pharmaceuticals's share price could reach $86.80 by Jan 5, 2027. The average Ionis Pharmaceuticals stock price prediction forecasts a potential upside of 5% from the current IONS share price of $82.67.

What is IONS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IONS) Ionis Pharmaceuticals's current Earnings Per Share (EPS) is -$1.61. On average, analysts forecast that IONS's EPS will be -$3.18 for 2026, with the lowest EPS forecast at -$4.26, and the highest EPS forecast at -$1.59. On average, analysts forecast that IONS's EPS will be -$1.58 for 2027, with the lowest EPS forecast at -$2.77, and the highest EPS forecast at -$0.01. In 2028, IONS's EPS is forecast to hit $1.61 (min: -$0.37, max: $3.37).

What is IONS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IONS) forecast ROE is 98.39%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.